Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer

Xiaolin Li1 Department of Geriatrics, the First Affiliated Hospital to Nanjing Medical University, Nanjing

Hua’e Xu2 Department of Pharmacy, the First Affiliated Hospital to Nanjing Medical University, Nanjing

Xinzheng Dai3 Key Laboratory of Living Donor Liver Transplantation, Ministry of Public Health, Nanjing;4 Liver Transplantation Center, the First Affiliated Hospital to Nanjing Medical University, Nanjing

Zhenshu Zhu5 Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing

Baorui Liu6 The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, ChinaCorrespondence[email protected] [email protected]

Xiaowei Lu1 Department of Geriatrics, the First Affiliated Hospital to Nanjing Medical University, NanjingCorrespondence[email protected] [email protected]

Pages 5183-5190 | Published online: 02 Oct 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin200959422524919474385
PubMed Web of Science ®Google Scholar
American Cancer SocietyCancer Facts and Figures 2012Atlanta, GAAmerican Cancer Society2012
Google Scholar
DiazJFAndreuJMAssembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competitionBiochemistry19933211274727558096151
PubMed Web of Science ®Google Scholar
StrumbergDErhardJHarstrickAPhase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinomaEur J Cancer1998348129012929849493
PubMed Web of Science ®Google Scholar
ChaoYChanWKBirkhoferMJPhase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patientsBr J Cancer199878134399662247
PubMed Web of Science ®Google Scholar
DorrRTPharmacology and toxicology of Cremophor EL diluentAnn Pharmacother199428Suppl 5S11S147915152
PubMedGoogle Scholar
BisseryMCNohynekGSanderinkGJLavelleFDocetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experienceAnticancer Drugs1995633393557670132
PubMed Web of Science ®Google Scholar
KangHSKimYHLeeCSLeeJJChoiIPyunKHAnti-inflammatory effects of Stephania tetrandra S. Moore on interleukin-6 production and experimental inflammatory disease modelsMediators Inflamm19965428029118475741
PubMed Web of Science ®Google Scholar
MengLHZhangHHaywardLTakemuraHShaoRGPommierYTetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1Cancer Res200464249086909215604277
PubMed Web of Science ®Google Scholar
WuJMChenYChenJCLinTYTsengSHTetrandrine induces apoptosis and growth suppression of colon cancer cells in miceCancer Lett2010287218719519586712
PubMed Web of Science ®Google Scholar
OhSHLeeBHInduction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c releaseBiochem Pharmacol200366572573112948852
PubMed Web of Science ®Google Scholar
FuLWZhangYMLiangYJYangXPPanQCThe multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cellsEur J Cancer200238341842611818209
PubMed Web of Science ®Google Scholar
ChoiSUParkSHKimKHThe bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoproteinAnticancer Drugs1998932552619625436
PubMed Web of Science ®Google Scholar
WeiJLiuBWangLQianXDingYYuLSynergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell linesCancer Chemother Pharmacol200760570371117256130
PubMed Web of Science ®Google Scholar
LiXLuXXuHPaclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy.”Mol Pharm20129222222922171565
PubMed Web of Science ®Google Scholar
LiXLiRQianXSuperior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rateEur J Pharm Biopharm200870372673418634874
PubMed Web of Science ®Google Scholar
ShaoJZhengDJiangZCurcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cellsActa Biochim Biophys Sin (Shanghai)201143426727421349881
PubMed Web of Science ®Google Scholar
HeroldDAKeilKBrunsDEOxidation of polyethylene glycol by alcohol dehydrogenaseBiochem Pharmacol198938173762642704
PubMed Web of Science ®Google Scholar
MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzyme Regul200141218920711384745
PubMedGoogle Scholar
IdaniHMatsuokaJYasudaTKobayashiKTanakaNIntra-tumoral injection of doxorubicin (Adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effectsInt J Cancer200088464565111058884
PubMed Web of Science ®Google Scholar
LiXZhenDLuXEnhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells – a possible Trojan strategy against cancerEur J Pharm Biopharm201075333434020438840
PubMed Web of Science ®Google Scholar
MaXWangHJinSWuYLiangXJConstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoylsn- glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activityInt J Nanomedicine201271313132822419875
PubMed Web of Science ®Google Scholar
WangJMongaytDTorchilinVPPolymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipidsJ Drug Target2005131738015848957
PubMed Web of Science ®Google Scholar
ShenoyDLittleSLangerRAmijiMPoly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluationsMol Pharm20052535736616196488
PubMed Web of Science ®Google Scholar
WalterKATamargoRJOliviABurgerPCBremHIntratumoral chemotherapyNeurosurgery1995376112811458584154
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date